Search

Issue
Title
Authors
Vildagliptin – 15 years in active service with diabetologists
Pavlova M.G.
INNOVATsIONNAYa SAKhAROSNIZhAYuShchAYa TERAPIYa: NOVAYa STRATEGIYa DLYa STAROY PROBLEMY
Antsiferov M.B., Schemthaner G., Ametov A.S.
TYPE 2 DIABETES MELLITUS: POTENTIALS FOR ACHIEVEMENT OF OPTIMAL CONTROL WITHOUT SIDE EFFECTS
Antsiferov M.B., Antsiferov M.B.
Vybor gliptinov v raznykh klinicheskikh situatsiyakh - kommentarii k portretam patsientov
Ruyatkina L.A., Sorokin M.Y.
SAXAGLIPTIN OPENS NEW OPPORTUNITIES FOR EFFECTIVE AND SAFE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Mkrtumyan A.M., Mkrtumyan A.M.
Mnogofaktornoe upravlenie sakharnym diabetom 2 tipa: kakovy nashi segodnyashnie vozmozhnosti
Galstyan G.R.
Prospects of the first human glucagon-like peptide 1 analog liraglutid use in the treatment of patients with type 2 diabetes mellitus
Antsiferov M.B., Dorofeeva L.G., Anciferov M.B., Dorofeeva L.G.
Vildagliptin - new opportunities in the treatment of type 2 diabetes mellitus
Pavlova M.G.
Osobennosti lecheniya narusheniy tolerantnosti k glyukoze u patsientov s abdominal'no-vistseral'nym tipom ozhireniya na rannikh etapakh ego razvitiya
Shilov A.M., Abdullaeva A.T.
Gastroenterological aspects of bariatric surgery
Simanenkov V.I., Tikhonov S.V.
APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS
Antsiferov M.B., Antsiferov M.B.
INCRETIN SYSTEM AS PROMISING PHARMACOLOGICAL TARGET FOR HYPOGLYCEMIC THERAPY
Kurkin D.V., Volotova E.V., Bakulin D.A., Lomkina E.M., Tyurenkov I.N.
Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu
Antsiferov M.B., Antciferov M.B.
Alogliptin - effektivnyy i bezopasnyy ingibitor dipeptidilpeptidazy-4 v terapii bol'nykh sakharnym diabetom 2 tipa
Mkrtumyan A.M.
SAXAGLIPTIN (ONGLYZA ®) IN CONCEPTION OF EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Petunina N.A., Brashchenkova A.V., Petunina N.A., Brashcenkova A.V.
KLINIChESKIE PREIMUShchESTVA PERVOGO ANALOGA ChELOVEChESKOGO GPP-1 LIRAGLUTIDA PRI LEChENII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA
Demidova I.Y.
CLINICAL ASPECTS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: BENEFITS FOR DIFFERENT GROUPS OF PATIENTS
Antsiferov M.B., Antsiferov M.B.
1 - 17 of 17 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies